Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 297-303

  Chuaqui, Rodrigo F ^a   Zhuang, Zhengping ^a   Emmert Buck, Michael R ^a   Liotta, Lance A ^a   Merino, Maria J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOMA IN SITU; CHROMOSOME 11Q; CLINICAL ARTICLE; FEMALE; GENE LOCATION; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; HETEROZYGOTE; HUMANS; HYPERPLASIA; MIDDLE AGED;

EID: 0031021557     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Page DL, Dupont WD, Rogers LW, Rados MS: Atypical hyperplastic lesions of the female breast. Cancer 1985, 55:2698-2708
2. Lagios MD: Heterogeneity of ductal carcinoma In situ of the breast. J Cell Biochem 1993, 17G:49-52
3. Tavassoli FA (Ed): Pathology of the Breast, Norwalk, CT, Appleton & Lange, 1992, pp 263-291
4. Zhuang Z, Merino MJ, Chuaqui R, Liotta LA, Emmert-Buck MR: Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer, Cancer Res 1995, 55:467-471
5. Sanz-Ortega J, Chuaqui R, Zhuang Z, Sobel M, Sanz-Esponera J, Liotta LA, Emmert-Buck MR, Merino MJ: Loss of heterozygosity in microdissected human male breast carcinoma. J Natl Cancer Inst 1995, 87:1408-1410
6. Chuaqui R, Vargas MP, Castiglioni T, Elsner B, Zhuang Z, Emmert-Buck MR, Merino MJ: Detection of loss of heterozygosity in microdissected fine needle aspiration specimens of breast carcinomas, Acta Cytol 1996, 40:642-648
7. Zhuang Z, Berttheau P, Emmert-Buck MR, Liotta L, Gnarra J, Linehan WM, Lubensky IA: A new microdissection technique for archival DNA analysis of specific cell populations in lesions less than one millimeter, Am J Pathol 1995, 146:620-625
8. Polymeropoulos MH, Xiao H, Rath DS, Merril CR: Dinucleotide repeat polymorphism at the int-2 proto-oncogene locus (INT2). Nucleic Acids Res 1990, 18:7468
9. Iwasaki H, Stewart PW, Dilley WG, Holt MS, Steinbrueck TD, Wells S, Donis-Keller H: A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have a combined informativeness of PIC 0.95. Genomics 1992, 13:7-15
10. Allred DC, O'Connell PO, Fuqua AW, Osborne CK: Immunohistochemical studies of early breast cancer evolution. Br Cancer Res Treat 1994, 32:13-18
11. Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powels TJ, Price P, McKinna A, Harrison S: Immunohistochemical distribution of c-erbB-2 in infiltrating and In situ breast cancer. Int J Cancer 1988, 42:842-845
12. Gusterson BA, Machin LG, Gullick WJ, Gibbs NM, Powels TJ, Elliot C, Ashley S, Monaghan P, Harrison S: c-erbB-2 expression in benign and malignant breast disease. Br J Cancer 1988, 58:453-458
13. Davidoff AM, Kerns B-JM, Iglehart JD, Marks JR: Maintenance of p53 alteration throughout breast cancer progression. Cancer Res 1991, 51:2605-2610
14. Poller DN, Roberts EC, Bell JA, Elston CW, Blamey RW, Ellis IO: P53 protein expression in mammary ductal carcinoma In situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum Pathol 1993, 24:463-4468
15. Eriksson ET, Schimmelpenning H, Aspenbald U, Zetterbberg A, Auer GU: Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease. Hum Pathol 1994, 25:1228-1233
16. Weinstat-Saslow D, Merino MJ, Manrow RE, Bluth RF, Wittnebel KD, Simpson JF, Page DL, Steeg PS: Overexpression of cyclin D1 mRNA distinguishes carcinomas of the human breast. Nat Med 1995, 1:1257-1260
17. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, Croce CM: Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 1995, 55:3003-3007
18. Devilee P, van Vliet M, van Sloun P, Dijkshoorn NK, Hermans J, Perason PL, Cornelisse CJ: Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 1991, 6:1705-1711
19. Andersen TI, Gaustad A, Ottestad L, Farrants GW, Nesland JM, Tveit KM, Borresen A-L: Genetic alterations of the tumor suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes & Cancer 1992, 4:113-121
20. Smith HS, Lu Y, Deng G, Martinez O, Krams S, Ljung B-M, Thor A, Lagios M: Molecular aspects of early stages of breast cancer progression. J Cell Biochem 1993, 17G:144-152
21. Radford DM, Fair K, Thompson AM, Ritter JH, Holt M, Steinbrueck T, Wallace M, Wells Jr SA, Donis-Keller D: Allelic loss on chromosome 17 in ductal carcinoma in situ of the breast. Cancer Res 1993, 53:2947-2950
22. O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC: Molecular genetic studies of early breast cancer evolution. Breast Cancer Res Treat 1994, 32:5-12
23. Lakhani SR, Collins C, Stratton MR, Sloane JP: Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J Clin Pathol 1995, 48:611-615
24. Stottler AT, McNeese M, Oswald MJ, Ames FC, Romsdahl MM: The role of limited surgery with irradiation in primary treatment of ductal in situ breast cancer. Int J Radiat Oncol Biol Phys 1990, 18:283-287
25. Lagios MD, Margolini FR, Westdahl PR, Rose MR: Mammographically detected ductal carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1990, 63:618-624